MA

Q2 2023 update: regenerative medicine related M&A activity in the pharmaceutical industry

Analysis of the key themes driving M&A activity reveals that regenerative medicine accounted for 4 pharmaceutical deals announced in Q2…

Q2 2023 update: M&A activity in pharmaceutical in Italy

In the Italian pharmaceutical industry, there were 7 M&A deals announced in Q2 2023, worth a total value of $53.9m,…

How big data M&A performed in the pharmaceutical industry in Q2 2023

Analysis of the key themes driving M&A activity reveals that big data accounted for 3 pharmaceutical deals announced in Q2…

M&A in pharmaceutical in Germany remained flat in Q3 2023

In the German pharmaceutical industry, there were 12 M&A deals announced in Q3 2023, worth a total value of $16.4m,…

Q3 2023 update: M&A activity in pharmaceutical in Australia

In the Australian pharmaceutical industry, there were 4 M&A deals announced in Q3 2023, worth a total value of $227.7m,…

M&A in pharmaceutical in Brazil decreased in Q2 2023

In the Brazilian pharmaceutical industry, there were 5 M&A deals announced in Q2 2023, worth a total value of $349.7m,…

Q3 2023 update: M&A activity in pharmaceutical in Singapore

In the Singaporean pharmaceutical industry, there were 5 M&A deals announced in Q3 2023, worth a total value of $163.1m,…

M&A in pharmaceutical in France decreased in Q3 2023

In the French pharmaceutical industry, there were 5 M&A deals announced in Q3 2023, worth a total value of $16m,…

M&A in pharmaceutical in Canada increased in Q3 2023

In the Canadian pharmaceutical industry, there were 22 M&A deals announced in Q3 2023, worth a total value of $1.2bn,…

How precision and personalized medicine M&A performed in the pharmaceutical industry in Q2 2023

Analysis of the key themes driving M&A activity reveals that precision and personalized medicine accounted for 6 pharmaceutical deals announced…